Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery
PIIINP-NGAL
Prospective Multicenter Study to Assess the Predictive Value of PIIINP and Urinary NGAL in Renal Function Recovery During Acute Tubular Necrosis
1 other identifier
observational
287
0 countries
N/A
Brief Summary
Acute Renal Failure (ARF) is defined by a severe, and usually reversible, glomerular filtration rate decreasing. Acute Tubular Necrosis (ATN) remain the major cause of ARF involving distress and destruction of tubular cells. This specific typology of ARF may evolve toward Chronic Renal Failure (CRF) concretizing a major public health issue. Predict the progression of ARF towards CRF appears essential. The investigators believe that the PIIINP and urinary NGAL biomarkers may constitute robust biomarkers of progression risk towards CRF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2012
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 24, 2016
CompletedFirst Posted
Study publicly available on registry
September 5, 2016
CompletedSeptember 7, 2016
August 1, 2016
2.5 years
August 24, 2016
September 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
PIIINP/Urinary Creatinine ratio levels between patients experimenting CRF or not.
We expect to highlight different ratio PIIINP/Urinary Creatinine levels and evolution between patients experimenting CRF or not (defined less than 60 mL/min according MDRD formula).
12months after initial diagnosis.
Secondary Outcomes (4)
NGAL/Urinary Creatinine ratio levels between patients experimenting CRF or not.
12, 18 and 24 months after initial diagnosis.
Correlation between NGAL/Urinary Creatinine and PIIINP/Urinary Creatinine ratios among patients with ARF.
3, 6, 12, 18 or 24 months after initial diagnosis.
Validation of high diagnostic performance of NGAL/Urinary Creatinine ratio to predict CRF occurrence.
3, 6, 12, 18 or 24 months after initial diagnosis.
Validation of high diagnostic performance of PIIINP/Urinary Creatinine to predict CRF occurrence.
3, 6, 12, 18 or 24 months after initial diagnosis.
Eligibility Criteria
Patients experimenting ARF in ATN context.
You may qualify if:
- off-age patient.
- ATN diagnosis based on 1) typical clinical environment (sepsis, nephrotoxicity...) 2) 50% decrease of glomerular filtration flow (according clearance MDRD) or more than 100micromol plasmatic creatinine increase. 3) no renal function improvement after efficient vascular filling (\>750cc normal saline or equivalent).
- Consent.
You may not qualify if:
- ARF not related with ATN context.
- Life expectancy less than 3 months.
- Protocol refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2016
First Posted
September 5, 2016
Study Start
April 1, 2012
Primary Completion
October 1, 2014
Study Completion
February 1, 2016
Last Updated
September 7, 2016
Record last verified: 2016-08